Repurposing, reformulation, and first-to-file generics in one decision environment. MolecuLens ranks high-value opportunities across regulatory, clinical, patent, commercial, and manufacturing intelligence — months of analysis in days.
Cross-indication discovery with AI biological-plausibility scoring and evidence synthesis.
Improved delivery systems and novel routes with technology-feasibility analysis.
Patent-expiry tracking, Paragraph IV analysis, and Orange Book intelligence.
Regulatory, patent/IP, commercial, clinical, and manufacturing intelligence in one framework.
Multi-dimensional scoring across scientific, regulatory, commercial, IP, and manufacturing.
Search by molecule, route of administration, or disease for ranked results.
Cross-indication discovery with AI biological-plausibility scoring and evidence synthesis.
Improved delivery systems and novel routes with technology-feasibility analysis.
Patent-expiry tracking, Paragraph IV analysis, and Orange Book intelligence.
Regulatory, patent/IP, commercial, clinical, and manufacturing intelligence in one framework.
Multi-dimensional scoring across scientific, regulatory, commercial, IP, and manufacturing.
Search by molecule, route of administration, or disease for ranked results.
Repurposing scores weighted by evidence quality, not just publication volume.
Patent FTO analysis runs inside the platform — no external vendor needed.
First-to-file radar covers Para IV filings in real time as they hit the FDA Orange Book.
Reports exportable as structured briefs for BD or licensing discussions.
Natural-language questions MolecuLens answers in seconds:
Book a walkthrough with the right specialist and we'll tailor it to your therapeutic area and the questions your team is asking.